Novo Nordisk A/S (NYSE:NVO)

Delayed Data
As of 3:59pm ET
 +0.66 / +0.72%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 202.40, with a high estimate of 235.00 and a low estimate of 102.96. The median estimate represents a +120.51% increase from the last price of 91.79.

Analyst Recommendations

The current consensus among 26 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.26%
Growthannually 46.28%


Growthquarterly 5.07%
Growthannually 27.25%
Key to the earnings and sales forecast charts.